$4.08
3.77% today
Nasdaq, Feb 28, 04:50 pm CET
ISIN
US71535D1063
Symbol
PSNL
Sector
Industry

Personalis Inc Stock price

$4.24
-1.57 27.02% 1M
-1.52 26.39% 6M
-1.54 26.64% YTD
+2.74 182.67% 1Y
-6.26 59.62% 3Y
-4.39 50.87% 5Y
-12.76 75.06% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-0.24 5.36%
ISIN
US71535D1063
Symbol
PSNL
Sector
Industry

Key metrics

Market capitalization $301.12m
Enterprise Value $202.63m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.32
P/S ratio (TTM) P/S ratio 3.44
P/B ratio (TTM) P/B ratio 1.80
Revenue growth (TTM) Revenue growth 24.05%
Revenue (TTM) Revenue $87.49m
EBIT (operating result TTM) EBIT $-70.09m
Free Cash Flow (TTM) Free Cash Flow $-54.65m
Cash position $143.65m
EPS (TTM) EPS $-1.68
P/E forward negative
P/S forward 3.76
EV/Sales forward 2.60
Short interest 5.86%
Show more

Is Personalis Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Personalis Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Personalis Inc forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a Personalis Inc forecast:

Buy
83%
Hold
17%

Financial data from Personalis Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
87 87
24% 24%
100%
- Direct Costs 60 60
9% 9%
69%
27 27
79% 79%
31%
- Selling and Administrative Expenses 35 35
18% 18%
40%
- Research and Development Expense 51 51
25% 25%
58%
-59 -59
38% 38%
-67%
- Depreciation and Amortization 11 11
15% 15%
13%
EBIT (Operating Income) EBIT -70 -70
35% 35%
-80%
Net Profit -91 -91
19% 19%
-105%

In millions USD.

Don't miss a Thing! We will send you all news about Personalis Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Personalis Inc Stock News

Neutral
Seeking Alpha
about 16 hours ago
Personalis, Inc. (NASDAQ:PSNL ) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants Caroline Corner - Investor Relations Christopher Hall - Chief Executive Officer and President Aaron Tachibana - Chief Financial and Chief Operating Officer Richard Chen - Executive Vice President, R&D, and Chief Medical Officer Conference Call Participants Thomas Flaten - Lake Stre...
Neutral
Business Wire
about 19 hours ago
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the fourth quarter and full year ended December 31, 2024, and provided recent business highlights. Recent Business Highlights Delivered 1,441 total molecular tests in the fourth quarter of 2024, an increase of 52% compared with 945 tests d...
Positive
Seeking Alpha
7 days ago
Today, I am highlighting three biotech/healthcare stocks that currently trade under $10 a share after some recent weakness. ! am slowly accumulating each of these names on these dips both straight equity purchases and covered call orders. All have had some recent positive despite the action in the shares and have good longer-term prospects.
More Personalis Inc News

Company Profile

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA.

Head office United States
CEO Christopher Hall
Employees 225
Founded 2011
Website www.personalis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today